Physicians' Academy for Cardiovascular Education

The ORBITA trial: is PCI beneficial in stable angina patients?

3' education - Mar. 9, 2018 - VBWG at ACC 2018, Orlando, FL, USA - Prof. William Boden, Boston, MA, USA

VBWG at ACC 2018 William Boden emphasizes the importance of using a sham control in clinical trials testing the effectivity of PCI and elaborates on this in respect to the ORBITA trial evaluating PCI treatment in patients with stable angina.

Educational information

This 3-minute education provides a summary of just presented scientific data, recorded during the VBWG meeting at ACC 2018. The objective is to provide a brief commentary and potential implications of these findings.


William E. Boden, MD, is Professor of Medicine at the Boston University School of Medicine, Boston, MA, USA.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: